Cognition Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cognition Therapeutics generated cash of -$16,018,000, which is more than the previous year. Cash used in financing activities reached the amount of $4,521,000 last year. Net change in cash is therefore -$11,640,000.
Cash Flow
| 2019 | -3.09M | -144K | 2.79M |
|---|---|---|---|
| 2020 | -3.43M | -10K | 5.76M |
| 2021 | -3.63M | -27K | 53.20M |
| 2022 | -18.53M | -171K | 5.54M |
| 2023 | -16.01M | -147K | 4.52M |
CGTX Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 41.56M | 54.72M | 5.18M | 2.89M | 3.39M |
Operating activities | |||||
Net income | -25.78M | -21.39M | -11.71M | -7.83M | -4.84M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 252K | 235K | 93K | 98K | 81K |
Stock-based compensation expense | 4.35M | 3.57K | 5.18M | 475K | 361 |
| Deferred income tax benefit | 4.35M | 3.57K | 5.18M | 475K | 361 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 2.39M | -1.40M | -1.11M | 3.00M | -1.11M |
Inventories | 0 | 1.40M | 1.11M | -3.00M | 1.11M |
Accounts payable | 0 | -1.09M | 2.16M | -364K | 862K |
Cash generated by operating activities | -16.01M | -18.53M | -3.63M | -3.43M | -3.09M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -147K | -171K | -27K | -10K | -144K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -147K | -171K | -27K | -10K | -144K |
Financing activities | |||||
Common Stock Issued | 5.33M | 5.32M | 44.21M | 47K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -811K | -1.39M | -268K | -4K | 2.82M |
Cash used in financing activities | 4.52M | 5.54M | 53.20M | 5.76M | 2.79M |
Net Change In Cash | -11.64M | -13.15M | 49.53M | 2.29M | -508K |
Cash at end of period | 29.92M | 41.56M | 54.72M | 5.18M | 2.89M |
| Data source | Data source | Data source |